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Abstract
The whole genome projects open the prelude to the diversity and complexity of 
biological genome by generating immense data. For the sake of exploring the riddle 
of the genome, scientists around the world have dedicated themselves in annotating 
for these massive data. However, searching for the exact and valuable information 
is like looking for a needle in a haystack. Advances in gene editing technology have 
allowed researchers to precisely manipulate the targeted functional genes in the 
genome by the state-of-the-art gene-editing tools, so as to facilitate the studies 
involving the fields of biology, agriculture, food industry, medicine, environment 
and healthcare in a more convenient way. As a sort of pioneer editing devices, the 
CRISPR/Cas systems having various versatile homologs and variants, now are 
rapidly giving impetus to the development of synthetic genomics and synthetic 
biology. Firstly, in the chapter, we will present the classification, structural and 
functional diversity of CRISPR/Cas systems. Then we will emphasize the applica-
tions in synthetic genome of yeast (Saccharomyces cerevisiae) using CRISPR/Cas 
technology based on year order. Finally, the summary and prospection of synthetic 
genomics as well as synthetic biotechnology based on CRISPR/Cas systems and 
their further utilizations in yeast are narrated.
Keywords: applications, CRISPR/Cas, gene editing, S. cerevisiae, synthetic genomics, 
yeast
1. Introduction
Synthetic biology is a fundamentally interdiscipline. It has become an important 
methodology in biotechnology owing to its novel functions and regulation mecha-
nisms. The scientific concept of synthetic biology can be traced back to the book “The 
Mechanism of Life” written by a French physical chemist Stéphane Leduc in 1911 [1]. 
It currently refers to the practical application discipline that integrating modern sci-
ence and engineering technology to promote and accelerate the design, alteration and 
creation of bio-genetic materials in living organisms [2]. Briefly, synthetic biology can 
roughly be considered as the reverse process of analytical biology. Sustained advances 
in synthetic biology will depend on coordinated and paralleled developments within 
many different discipline areas, and cooperation of scientists from most countries. 
In China, scientists have made landmark contributions in this field with the success 
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of artificial synthesis of bovine insulin and yeast (S. cerevisiae) alanine transfer 
RNA. In USA, artemisinic acid, a precursor of antimalarial drug artemisinin, was 
synthesized in S. cerevisiae with a yield of 25 g/L, and has been industrialized in 2013 
[3]. Nowadays, synthetic biology is rapidly penetrating into various fields including 
bio-science, gene engineering, agriculture, food industry and medicine, in which syn-
thetic genomics plays a profound role in providing theoretical basis and technological 
support. Synthetic genomics is viewed as an important area of synthetic biology, 
which being engineered under a general genome scope, mainly refers to design and 
assembly of nucleotide fragments to generate functional living genomes [4], includ-
ing recreated and recoded genomes as well as minimal genomes. Genetic manipula-
tion is known as one of the central strategies to investigate the molecular basis of 
living things as well as their evolution and diversity, which advancing the understand-
ing of biological systems at a micro level. Compared to conventional approaches in 
genetic manipulation, synthetic genomics has the characteristics of introducing large 
numbers and diversity of genetic modifications [5]. Additionally, synthetic genomics 
can theoretically create a synthetic genome to practically and feasibly build a simpler 
and more amenable genome-scale platform for biological system construction [6].
In a certain sense, the first synthetic gene synthesized in 1970s [7] marked the 
beginning of synthetic genomics. Then, viral chromosomes were the first to be syn-
thesized in the early 2000’s because of their comparatively small size [8]. Nowadays, 
as a first designer synthetic eukaryotic genome, Sc2.0 (S. cerevisiae 2.0) project 
has achieved significant progresses including real-world applications for industrial 
microbiology, and may create a big economic value in the future. Driven by rapid 
advances in gene assembly, genome editing and mathematical modeling techniques, 
synthetic genomics is developing quickly. As a young discipline, synthetic genomics 
has helped to promote our new understanding of genome structure and function. 
Recently, an important direction of synthetic genomics is to transform the natural 
biological systems through gene editing techniques. With emerging novel classes 
of programmable genetic tools, in particular, the establishment and optimization 
of CRISPR and associated technology platforms, synthetic biology and its vital 
field——synthetic genomics is entering a new era of more possibilities. Actually, 
early in 2014, the European Commission’s synthetic biology summit has typically 
categorized synthetic biology tools as design, construction and diagnostic tools 
whereas synthetic biology methodology serves the study of DNA synthesis and syn-
thetic genomics, engineering biology, xenobiology as well as protocell biology [9]. 
CRISPR/Cas nucleases have been extensively applied to manipulate the genomes of 
cultured and primary cells, animals and plants, vastly accelerating the pace of basic 
research and enabling breakthroughs in the field of synthetic biology and synthetic 
genomics [10]. It can be expect that, CRISPR toolkits are of particular importance 
to the future of synthetic genomics due to its great potential to open new pathways 
for manipulation and expression of genetic information, which will certainly 
transform synthetic genomics and synthetic biology greatly.
Here in this chapter, we review the developments of CRISPR/Cas technology, the 
main types of CRISPR/Cas system, as well as the applicational research of synthetic 
genomics in yeast using CRISPR/Cas toolboxes. Finally, we also provide perspec-
tives on future directions and applications of CRISPR/Cas-based methodology in 
the research of synthetic yeast genome.
2. CRISPR/Cas: a powerful and versatile toolkits for synthetic genomics
The survival battle between microbes and bacteriophage is the driving force 
behind the evolution and diversification of microbial adaptive immune system. 
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As part of the immune response in bacteria, CRISPR/Cas systems are responsible 
for tackling the invading phages or plasmids. These systems are of particular impor-
tance to the future of synthetic genomics owing to their great potential to open new 
doors for manipulation and expression of genetic sequences. Since the discovery 
of CRISPR in the Escherichia coli genome in 1987 [11], CRISPR/Cas systems now 
have been classified into two main classes (Class 1 and Class 2) and six types (type 
I, II, III, IV, V and VI) covering over 30 different subtypes [12]. The diversities of 
architecture and classification render CRISPR/Cas systems with broad functional 
versatilities. Of note, the diversity of protospacer adjacent motif (PAM) is also an 
important feature for CRISPR/Cas systems. Briefly, PAM refers to a short sequence 
resides in the exogenous nucleic acid elements (commonly at the 3′ end of the target 
DNA) but not the CRISPR array and its guide RNAs that support to discriminate 
self versus non-self of microbes’ nucleic acid ingredients. The nucleotide sequences 
that can be edited by CRISPR/Cas systems have been limited by the PAM and 
gRNA sequences. Commonly, Streptococcus pyogenes Cas9 (SpCas9) recognizes 
5’-NGG-3′, and Staphylococcus aureus Cas9 (SaCas9) recognizes 5’-NNGRRT-3′ as 
their respective functional PAM [13]. However, type V CRISPR/Cas system uses a 
T-rich PAM sequence such as “TTT”, “TTA”, “TTN” or “TTC” for target recogni-
tion. For example, Cas12a (Cpf1) uses the “TTN” PAM sequence to target dsDNA 
[14]. Cas proteins and their variants require different PAM sequences for efficiently 
and precisely manipulate and cleavage biological genomes, while type VI system 
relies on a PAM analogue termed protospacer flanking site (PFS) for RNA targeting 
[15]. Moreover, taking Cas9 protein as an example, a previous study has reported 
the important function of PAM recognition in the field of inducing target DNA 
unwinding, which underscored by the sequential variability of PAM recognition 
presented in engineered Cas variants [16].
In addition to the basic properties for antiviral roles, CRISPR/Cas systems have 
numerous potential applications for gene editing, transcriptional activation/inhibi-
tion, epigenetic modification, chromatin imaging, single base substitution, point-
of-care diagnostics [17] and synthetic biology, among others [18]. However, taking 
account of off-target concerns, much more interrogations are needed to make these 
systems valuable and reliable toolboxes for utility research area.
As CRISPR systems continue to be discovered, a variety of programmable nucle-
ases have joined the ranks of genome editing. Currently, three types of candidate 
nuclease systems including Cas9 and its homologs, DNA-targeting Cas12, as well 
as RNA-targeting Cas13 have together become the focus of gene-editing technol-
ogy. Cas9 nuclease induces double strand breaks (DSB), and Cas9 nickase triggers 
single strand breaks (SSB); whereas dCas9 (dead Cas9) derived from Cas9 nuclease 
via mutating the HNH nuclease domain and RuvC-like domain, can still bind to 
the target region for transcriptional interventions, but without introducing a DSB. 
Based on similar mechanisms, dCas12a and dCas13 are capable to mediate CRISPR 
interference (CRISPRi) and CRISPR activation (CRISPRa) at the transcriptional 
levels. CRISPRi/a is a tremendously useful tool for transcriptional regulations which 
achieving by covalent modification of histones of Cas proteins as it allows to balance 
and optimize gene expression without genome editing. Besides, Cas9 and Cas12a 
(previously named as Cpf1) are RNA-guided endonucleases that can induce genome 
editing by triggering DSB repair at a specific site [19]. Cas9 and Cas13a can be used 
for targeted RNA interference. Cas13a fused to base editors can be used to modify 
nucleotides in RNA. Futhermore, the dCas nucleases have termed “discovery-based 
synthetic biology”, constitute one part of toolbox to study synthetic biology and 
engineer biology, especially have functions in the field of characterizing the func-
tion of noncoding genes and regulatory elements of the genome, and strategies to 
design synthetic gene circuits [20]. Theoretically, CRISPR toolkits can be applied 
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to integrate synthetic sequences into the genome, to form genomic libraries, and 
to target on multiple functional loci conveniently for gene modifications with high 
efficiency in strains or cell lines. The increased knowledges of CRISPR classifica-
tions and their action mechanisms open up new scopes of applications in synthetic 
genome of an organism via these systems.
3.  Synthetic genomics and the use of CRISPR technology in synthetic 
genomics of S. cerevisiae
Technical advances in chemical synthesis of poliovirus cDNA in the absence of 
a natural template have gained global attentions. The successful synthesis of the 
7,740 bp poliovirus cDNA artificially not only indicated the feasibility of producing 
infectious virus using chemically synthesized oligonucleotides as initial materials but 
also showed the great potential of modifying and creating more complex genomes 
under laboratory conditions [21]. Then in 2003, the artificial synthesis of ΦX174 
bacteriophage genome (5,386 bp) using synthetic oligonucleotides has paved the way 
for synthesizing bacterial genomes [22]. Since then, several other viral genomes and 
transposons have also been synthesized in their entirety. Bacterial genomes com-
prising millions of base pairs are very complex, which often regarded as advanced 
factories to synthetise biologically active chemical substances. Synthetic biologist 
Craig Venter and his research team have successively synthesized the 582,970 bp 
Mycobacterium genitalium genome and Mycoplasma mycoides genome JCVI-1.0, and 
the latter represented a milestone in the history of synthetic  genomics [23, 24].
From historical perspective of human domestication, potentially the next best 
thing to fire is yeast [25]. In practical terms, yeast represents one of the simplest 
eukaryotic microorganisms, and as an attractive model organism has been widely 
used in the food industry [26]. The Synthetic Yeast Genome (Sc2.0) Project is on-
going and aims to explore yeast chromosome structure, minimal eukaryotic genome 
length and gene content, as well as to rewrite all 16 yeast chromosomes. As we 
known, DNA synthesis is an essential tool for synthetic genomics. Currently, with 
the aid of CRISPR/Cas technology, for instance, programmable Cas9 proteins can 
execute sequence-specific DSB depending on the target sites of the gRNA, and also 
genes in the genome of an organism can be programmed and are rewritable [27]. 
Generally, CRISPR/Cas systems have vastly simplified genome editing in yeasts via 
performing gene over-expression, knockin, knockout, mutations and deletions, 
and enabled easy-operation genetically engineering of products of fuel molecules, 
chemical components, food ingredients, and active pharmaceutical ingredients.
Early in 2013, DiCarlo and colleagues firstly piloted CRISPR/Cas9 system to 
engineer for site-specific mutagenesis and allelic replacement in the genome of 
S. cerevisiae using dsOligo (double-stranded 90-bp oligonucleotide) as a template 
with efficiency rates close to 100% [28]. A few months later, Farzadfard’s research 
team reported a CRISPR/Cas-based eukaryotic transcriptional regulation system 
implemented in S. cerevisiae, which will open up new paths for drawing natural 
genetic circuits and their regulations regarding on cellular phenotypic mechanisms 
[29]. In the years following these initial works, several related research reports have 
been emerging.
In 2014, Ryan and others improved the utilization of fiber disaccharide in 
diploid yeast by multiplex CRISPR system, which made the cellobiose fermentation 
rates increased by more than 10 times [30]. Similarly as DiCarlo’s experimental 
methodology, Zhang et al. engineered the industrial polyploid strain ATCC4124, 
where URA3, TRP1, LEU2 and HIS3 were knocked out one-by-one with efficiencies 
varying from 15–60% to create an auxotrophic strain. And this method is likely to 
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be very valuable for yeast genome engineering due to having no need of selectable 
markers that labeled in the integrated DNA [31].
In 2015, Bao et al. and Mans et al. respectively, used a HI-CRISPR (homology-
integrated CRISPR) or CRISPR/Cas9 strategy to successfully generate multiple gene 
modifications in yeast S. cerevisiae simultaneously [32, 33]. In the studies related 
to metabolic pathway engineering, Ronda et al. applied a new system called CrEdit 
(CRISPR/Cas9 mediated genome Editing) to enable simultaneous and highly 
efficient integration of three pathway genes (BTS1, crtYB and crtI) involved in the 
production of β-carotene at three different integration sites (X-3, XI-2, and XII-5 
gene locus) in the genome of S. cerevisiae [34]. Jakočiūnas and collaborators applied 
CRISPR/Cas9 for multiplex gene knock-out to search for strains with improved 
production of mevalonate (a key intermediate for isoprenoid and sterol production) 
in yeast [35], followed by the utilization of CRISPR/Cas9 system to integrate crtYB, 
CrtI and crtE genes in three gene sites (ADE2, HIS3 and URA3) of S. cerevisiae for 
successfully constructing carotenoid biosynthesis pathway [36].
In 2016, more studies in relation to the use of CRISPR/Cas9 system for 
engineering in the genome of yeast have been reported [37–44]. Most notably, 
Tsarmpopoulos et al. reported the CRISPR/Cas9 adaptation for the engineering of 
bacterial genomes cloned in yeast. The result showed that applying 90 nt paired 
oligonucleotides as templates to promote recombination which achieved a seamless 
deletion of the mycoplasma glpO (glycerol-3-phosphate oxidase-encoding) gene 
without selection in one step. This work paves the way to high-throughput manipu-
lation of natural or synthetic genomes in yeast S. cerevisiae [37].
In the year of 2017, Vanegas and her partners used a combination tool of Cas9 
genome editing and dCas9 transcriptional regulation to engineer S. cerevisiae for 
production of flavonoid precursor naringenin and simultaneously restrainting 
formation of by-product phloretic acid [45]. Reider Apel et al. constructed a clone-
free toolkit based on CRISPR/Cas9, which solved the problems of chromosome 
integration locus and promoter selection, protein localization and solubility in 
yeast metabolic engineering, and optimized the expression of taxadiene synthase 
by using the tool, which increased the yield of taxadiene by 25 times [46]. Contrary 
to the result of protein overexpression, Vigentini et al. employed the CRISPR/
Cas9 system to successfully reduce urea production in S. cerevisiae wine yeasts via 
eliminating the CAN1 arginine permease pathway [47]. Interestingly, Mans et al. 
used CRISPR/Cas9 technology to explore the elusive mechanism for lactate export 
in S. cerevisiae. The 25-deletion strain in this experiment has taken the first step 
in building a yeast’s ‘minimal transportome’ platform, which can be applicable to 
functional explanation of heterologous transport proteins and the assessment of 
metabolic engineering strategies [48]. The summary of CRISPR-based studies in 
yeast in the year of 2017 have showed in Table 1 [45–59].
In the beginning of the year 2018, Verwaal et al. employed three gene-editing 
systems, Cpf1 orthologues (Acidaminococcus spp. BV3L6 (AsCpf1), Lachnospiraceae 
bacterium ND2006 (LbCpf1) and Francisella novicida U112 (FnCpf1)) for genome 
modification of S. cerevisiae. The result of this work demonstrated that Cpf1 can 
broaden application sphere of the genome-editing toolbox available for research of 
S. cerevisiae [69]. Li et al. firstly used the CRISPR/Cpf1 to delete large DNA frag-
ment (the deletion of DNA fragment of ∼38 kb between the two genes of TRM10 
and REX4) in S. cerevisiae, which demonstrating that the CRISPR/Cpf1 system can 
be used for genome simplification of S. cerevisiae, and to facilitate the laboratory 
evolution of the genome of S. cerevisiae [70]. Later in the year, Dank et al. used 
CRISPR/Cas9 technology to construct S. cerevisiae mutants with lacking esterase 
IAH1 and/or TIP1. Very interestingly, not affecting by the double gene knockout 
of yeast mutant ΔIAH1ΔTIP1, a complex regulatory mechanism to compensate 
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multiple genomic defects in aroma metabolism is generated and activated to show 
an aroma composition comparable to wild type levels [71]. Using CRISPR technol-
ogy, the related studies in yeasts for creating genome mutations and integrations 
have also been respectively carried out by Guo et al. [72] and Jakociunas et al. [73]. 
And much more related works have listed in Table 1 [60–68, 74].
As CRISPR systems continue to be extensively used, dozens of articles (more 
than 60 scientific papers in PubMed) in relation to CRISPR-based yeast have been 
published in 2019. Based on PubMed database, 2019 is the year of the most articles 
published in recent years in the field of CRISPR-edited yeasts. Among them, 
Zhang et al. deleted 6 genes in the yeast genomes in 3 days through developing a 
multiplexed gene-editing platform termed GTR-CRISPR (a gRNA-tRNA array 
for CRISPR/Cas9) with 60% efficiency using reported gRNAs and 23% using 
unimproved gRNAs. They further concluded that GTR-CRISPR may be suggested 
to the most valuable complement for the toolkit of synthetic biology and auto-
operation [75]. Notably, Laughery et al. found that the cause of dCas9 targeting 
boosted mutagenesis in yeast is likely affected mutationally by dCas9-mediated 
R-loop formation. These findings not only showed important implications for the 
applications of additional mutagenesis in dCas9 (and Cas9), but also offered a novel 
method for interrogating the mechanism of targeted R-loop formation induces 
eukaryotic genome variability and/or mutagenesis [76]. As excellent as above two 
work, another two investigations respectively described the CRISPR/Cas9 based 
functional chromosome fusions [77] and CRISPR/dCas9 based AND gate in yeast 
[78]. Additionally, as typical research examples, this review only list 5 valuable 
articles published in 2019 (Table 2) [79–83].
Good works are also seen in 2020. Wu and his team found that specific cleav-
age via CRISPR/Cas9 near the centromere of a S. cerevisiae chromosome can lead 
to elimination of the whole chromosome and initiate chromosome drive [89]. van 
Wyk et al. utilized CRISPR/Cas9 technology to generate a self-cloned wine yeast 
strain that over-expresses two genes of oenological relevance, GPD1 (glycerol-
3-phosphate dehydrogenase 1) and ATF1 (alcohol acetyltransferase 1), which 
directly implicated in glycerol and acetate ester production respectively. The result 
provided an alternative strategy to obtain increased glycerol and lower acetic acid 
levels, without disrupting the aldehyde dehydrogenase activity [90]. In addition to 
the above two, here enumerate 5 representative literatures on CRISPR-based yeasts 




































































References Authors/year Gene regulation Cas modes Target loci Descriptions
[79] Ai et al./2019 Deletion Cas9 gal80 Engineered yeasts that can produce artemisinic acid without galactose induction.
[80] Chen et al./2019 down-regulation 
or knock-out
Cas9 erg9; rox1; ypl062w; 
yjl064w
Achieved high production of valencene through CRISPR/Cas9-mediated 
metabolic engineering.
[81] Laughery et al./2019 Genome editing Cas9 RNR1 gene Describe a simple protocol for constructing Cas9-expressing plasmids and 
protocols for genome editing in yeast.
[82] Ciurkot et al./2019 Genome editing Cas12a INT1, INT2 and 
INT3 genomic sites
Demonstrated Cas12a-mediated multiplex genome editing in yeasts, and created 
yeast pixel art with an acoustic liquid handler using yeast strains that producing 
differently colored carotenoid.
[83] Yan & 
Finnigan/2019
Gene drive Cas9 HIS3 locus Developed a gene drive in yeasts that allowing for the examination of alternative 
drive designs and control mechanisms.
[84] Cámara et al./2020 Gene expression CRISPR/Cas PDR12 locus Constructed a toolkit for CRISPRa/i for a polyploid industrial yeast strain.
[85] Levi & Arava/2020 Gene modification Cas9 HTS1; OM14; FRS1 Provided a facile alternative to manipulate the yeast genome.
[86] Li et al./2020 Genome 
engineering
Cas9 UPC2 gene; Gal1-7, 
Gal80 sites
Cas-3P allowed single-, double- and triple-loci gene targeting in yeasts.
[87] Mitsui et al./2020 Genome evolution GMES
/CRISPR
13 genes: HXT7, 
HXK2, PGI1, etc.
Aimed to construct a lactic acid-tolerant yeast to reduce the neutralization cost in 
LA production.
[88] Yang et al./2020 Gene targeted 
mutation
Cas9 ERG20 Facilitate construction of genomic mutations of essential genes for functional 
genomic analysis and metabolic flux regulation in yeasts.
Note: CRISPRa/i, CRISPR activation and interference; Cas-3P, Cas9 and three marked plasmid backbones; GMES/CRISPR, global metabolic engineering strategy/CRISPR.
Table 2. 
CRISPR-based applications in yeast in the year of 2019.
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Stepping into 2021, innovations remain advancing. Gong et al. reported a  
gRNA-tRNA array and SpCas9-NG (GTR 2.0) for the applications of highly effi-
cient genome damage and base editing. In this study, they achieved gene cleavages 
with almost 100 efficiencies in the cells of S. cerevisiae. During the process, gene 
editing includes all 16 possible NGN PAMs and all 12 possible single-nucleotide 
mutations (N to N). Further, they employed GTR 2.0 system for multiplexed single-
nucleotide mutations to simultaneously produce 4 single-nucleotide conversions in 
single gene with 66.67% mutation efficiency, and to create simultaneously 2 single-
nucleotide mutations in two different genes with 100% mutation efficiency [91].
McGlincy et al. showed a comprehensive yeast CRISPRi library, based on 
empirical design rules, containing 10 distinct guides for most genes, which provid-
ing a strategy for genome-wide CRISPR interference screening in budding yeast 
[92]. Furthermore, a short communication introduced a GDi-CRISPR system (gene 
drive delta site integration system by the CRISPR system) for multi-copy integra-
tion in S. cerevisiae, which holds great promising for advancing the development of 
S. cerevisiae multi-copy integration tools [93].
4. Future challenges and prospections in the applications
As an emerging field, synthetic biology has high potential applications in drug-
discovery, development of medical therapeutics, diagnostic tools and improvement 
of bioproducts. And its emerging applications include vaccine development, cancer 
treatment, prevention and treatment of infection, microbiome engineering, cell 
therapy and regenerative medicine, biofuels as well as genome engineering [94]. 
New technologies, such as CRISPR/Cas-mediated genome editing, will enable syn-
thetic biologists to take a more holistic engineering approach, modifying synthetic 
circuits and the host genome with relative ease [95]. Nowadays, the CRISPR/Cas 
system is only 8 years old. With great progress in gene editing technology, CRISPR/
Cas systems surely will greatly boost the development of gene therapy, basic bio-
logical research, and synthetic biology, let alone in the research field of S. cerevisiae. 
However, the applications of CRISPR/Cas systems have still encountered several 
major challenges including off-target effects, delivery modalities, Cas9 cleavage 
activities and immune responses.
Off-target effects of CRISPR/Cas systems usually result from mismatches 
between the guide RNAs and their target gene sequences [96], and may result in 
targeting to unexpected sequences of nucleic acids. Many efforts have been done to 
lower unwanted off-target effects of CRISPR/Cas. Previous studies reported that the 
systems could effectively maximize on-target activity and minimize off-target effects 
for genome engineering either by modifying guide RNA or Cas9 nuclease [97, 98].
5. Conclusion
Thanks to the eximious predominance of yeast genetics, the organism S. cerevi-
siae has enjoyed gene regulation technology for decades. In spite of some limitations 
needed to be conquered, the advent of the CRISPR techniques have undoubtedly 
created a new era for genomic engineering in yeasts. CRISPR/Cas system as one of 
the most cutting-edge biotechnology will continue to not only improve our insight 
into the complexity of cells but also help us make better utilization of living sys-
tems. Taking together, the use of CRISPR/Cas systems for various synthetic biology 
applications, specially in the synthetic genome of yeast S. cerevisiae, has greatly 
accelerate food industry, biomedical study and agricultural research.
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